0QLX.LSE METALL ZUG AG Part. Cert.
- Market cap
- GBP 300M
- P/E
- 7.7x
- P/B
- -
- ROE
- -5.5%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.
Is 0QLX.LSE undervalued?
Graham numberThe Graham number of METALL ZUG AG Part. Cert. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
METALL ZUG AG Part. Cert. fundamental analysis
No fundamental analysis for METALL ZUG AG Part. Cert. yet.
METALL ZUG AG Part. Cert. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About METALL ZUG AG Part. Cert.
Metall Zug AG, through its subsidiaries, engages in the medical devices, infection control, technology cluster and infrastructure, and other businesses in Switzerland, Europe, North America, South America, the Asia Pacific, and internationally. The company develops, manufactures, and distributes devices and solutions for medical diagnosis, microsurgery, and eye training. It also offers diagnostics equipment, such as slit lamps, tonometry devices, and perimetry and biometry e…
Full company profileMETALL ZUG AG Part. Cert. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
METALL ZUG AG Part. Cert. annual financial statements
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 939M | 937M | 1.17B | 1.20B | 824M | 662M | 646M | 495M | 283M | 195M | 382M |
| Gross Profit | 308M | 274M | 252M | 237M | 261M | 228M | 227M | 152M | 90.9M | 61.4M | 130M |
| Operating Income | 80.8M | 89.4M | 130M | 86.0M | -2.18M | 20.7M | 34.3M | 13.8M | -23.8M | -26.3M | -22.2M |
| EBITDA | 126M | 94.5M | 124M | 86.2M | 41.0M | 57.6M | 146M | 23.8M | 65.4M | -17.5M | -4.42M |
| Net Income | 84.9M | 67.7M | 63.6M | 29.2M | 14.3M | 48.8M | 130M | 22.2M | 52.6M | -15.2M | -21.5M |
| EPS | 191 | 151 | 142 | 65 | 32 | 109 | 290 | 49 | 117 | -34 | -48 |
| Balance Sheet | |||||||||||
| Total Assets | 1.15B | 1.19B | 1.11B | 1.08B | 635M | 716M | 701M | 691M | 633M | 667M | 698M |
| Total Liabilities | 261M | 268M | 340M | 321M | 152M | 199M | 183M | 169M | 147M | 218M | 244M |
| Shareholders' Equity | 887M | 921M | 699M | 691M | 418M | 451M | 453M | 456M | 419M | 384M | 388M |
| Cash & Short-term Investments | 544M | 525M | 227M | 156M | 72.3M | 81.8M | 31.7M | 29.8M | 17.2M | 16.2M | 16.5M |
| Total Debt | 500K | 240K | 5.48M | 4.98M | 4.65M | 4.17M | 17.0M | 36.6M | 82.8M | 154M | 174M |
| Cash Flow | |||||||||||
| Operating Cash Flow | 95.5M | 90.2M | 336M | 56.9M | 60.2M | 48.9M | -6.02M | 16.6M | 7.57M | -3.78M | 40.7M |
| Capital Expenditure | 60.8M | 61.5M | 86.9M | 79.7M | 38.1M | 31.7M | 33.1M | 36.2M | 32.6M | 44.5M | 99.3M |
| Free Cash Flow | 34.8M | 28.7M | 249M | -22.9M | 22.1M | 17.3M | -39.1M | -19.6M | -25.0M | -48.2M | -58.6M |
| Ratios | |||||||||||
| ROE | 9.6% | 7.3% | 9.1% | 4.2% | 3.4% | 10.8% | 28.7% | 4.9% | 12.5% | -4.0% | -5.5% |
| ROA | 7.4% | 5.7% | 5.7% | 2.7% | 2.3% | 6.8% | 18.5% | 3.2% | 8.3% | -2.3% | -3.1% |
| Net Profit Margin | 9.0% | 7.2% | 5.4% | 2.4% | 1.7% | 7.4% | 20.1% | 4.5% | 18.6% | -7.8% | -5.6% |
| Debt to Equity | 0.00x | 0.00x | 0.01x | 0.01x | 0.01x | 0.01x | 0.04x | 0.08x | 0.20x | 0.40x | 0.45x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
METALL ZUG AG Part. Cert. dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | 8.95M | 20 | - |
| 2024 | CHF 9.00M | 20 | 17.1% |
| 2023 | CHF 13.5M | 30 | 60.6% |
| 2022 | GBP 13.4M | 30 | 10.3% |
| 2021 | GBP 7.62M | 17 | 15.6% |
| 2020 | GBP 7.62M | 17 | 53.2% |
| 2019 | GBP 31.4M | 70 | 107.4% |
| 2018 | GBP 31.4M | 70 | 49.5% |
| 2017 | GBP 31.4M | 70 | 46.4% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns METALL ZUG AG Part. Cert.
- Insiders 34.54%
- Institutions 10.03%
- Public & others 55.42%
- Shares outstanding 449K
- Free float 226K
METALL ZUG AG Part. Cert. company profile
- Company name
- METALL ZUG AG Part. Cert.
- Ticker
- 0QLX.LSE
- Exchange
- London Exchange
- Sector
- Healthcare
- Industry
- Commercial Services & Supplies
- Employees
- 869
- Fiscal year end
- December
- Address
- Industriestrasse 66, Zug, Switzerland, 6302
- Phone
- 41 58 768 60 50
- Website
- metallzug.ch
About METALL ZUG AG Part. Cert.
Metall Zug AG, through its subsidiaries, engages in the medical devices, infection control, technology cluster and infrastructure, and other businesses in Switzerland, Europe, North America, South America, the Asia Pacific, and internationally. The company develops, manufactures, and distributes devices and solutions for medical diagnosis, microsurgery, and eye training. It also offers diagnostics equipment, such as slit lamps, tonometry devices, and perimetry and biometry equipment for cataract diagnosis and treatment; equipment for ophthalmologists, including tables, chairs, and industrial high-precision surgical microscopes; accessories, including measuring instruments for precision optics, lenses, software solutions, and comprehensive services; and augmented and virtual reality technology and digital imaging for the training and further education of eye care specialists. In addition, the company supplies dishwashers, thermal appliances, and cleaning agents for catering and hotel sectors. Further, it engages in the management and development of real estate. The company was formerly known as Metallwaren-Holding AG and changed its name to Metall Zug AG in September 2002. Metall Zug AG was founded in 1887 and is headquartered in Zug, Switzerland.
METALL ZUG AG Part. Cert. management
4- Dr. Matthias ReyChief Executive Officer · born 1982
- Mr. Urs ScherrerChief Financial Officer · born 1980
- Bettine KillmerHead of Corporate Communications & IR
- Mr. Christoph SchupbachHead of Wire Processing Business Unit · born 1966